Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02935361
Title Guadecitabine and Atezolizumab in Treating Patients With Advanced Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia That Is Refractory or Relapsed
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Southern California
Indications

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

Therapies

Atezolizumab + Guadecitabine

Age Groups: senior | adult
Covered Countries USA


No variant requirements are available.